Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

Identifieur interne : 005004 ( Main/Exploration ); précédent : 005003; suivant : 005005

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

Auteurs : Jeffrey H. Kordower [États-Unis] ; Thomas B. Freeman [États-Unis] ; Er-Yun Chen [États-Unis] ; Elliott J. Mufson [États-Unis] ; Paul R. Sanberg [États-Unis] ; Robert A. Hauser [États-Unis] ; Barry Snow ; C. Warren Olanow [États-Unis]

Source :

RBID : ISTEX:4FFEC84A3634AFB88899927AE47466D6E748793D

Descripteurs français

English descriptors

Abstract

We have previously demonstrated that fetal nigral grafts can survive, reinnervate the striatum, and mediate clinically relevant recovery in a patient with Parkinson's disease (PD).1 Most previous autopsy cases have failed to identify meaningful numbers of viable grafted cells suggesting that differences in critical transplant variables determine graft viability. 2–4 The present study evaluated the structural and functional correlates of fetal nigral transplantation in a second PD patient who received fetal nigral grafts according to our previously published transplant protocol. 5 A 61‐year‐old woman with severe PD received bilateral fetal nigral grafts to the post commissural putamen from seven donor fetuses (four right side and three left side) aged 6.5‐9 weeks postconception. This patient died 19 months after surgery from a cause unrelated to the transplant surgery. Her postoperative clinical course was characterized by improved motor and activities of daily living scores during “off time,” reduced “off time,” and increased “on” time without dyskinesia. Positron emission tomography (PET) scans revealed a bilateral and progressive increase in fluorodopa (FD) uptake within the grafted putamen. Postmortem examination of the right hemisphere revealed large ovalshaped grafts containing more than 138,000 tyrosinehydroxylase‐immunoreactive (TH‐ir) neurons. Grafted cells formed a seamless border with the host and provided dense TH‐ir innervation to 78% of the host postcommissural putamen. Graft‐mediated sprouting of host fibers was not observed. These data provide essential confirmation that, under appropriate transplant conditions, grafted nigral neurons can survive, reinnervate the host striatum, and provide clinical benefit to PD patients. These findings also support the concept that improved motor function and striatal FD uptake on PET after nigral grafting in PD are the result of the viability of grafted neurons and graft‐derived reinnervation of the host striatum.

Url:
DOI: 10.1002/mds.870130303


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease</title>
<author>
<name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name>
</author>
<author>
<name sortKey="Freeman, Thomas B" sort="Freeman, Thomas B" uniqKey="Freeman T" first="Thomas B." last="Freeman">Thomas B. Freeman</name>
</author>
<author>
<name sortKey="Chen, Er Un" sort="Chen, Er Un" uniqKey="Chen E" first="Er-Yun" last="Chen">Er-Yun Chen</name>
</author>
<author>
<name sortKey="Mufson, Elliott J" sort="Mufson, Elliott J" uniqKey="Mufson E" first="Elliott J." last="Mufson">Elliott J. Mufson</name>
</author>
<author>
<name sortKey="Sanberg, Paul R" sort="Sanberg, Paul R" uniqKey="Sanberg P" first="Paul R." last="Sanberg">Paul R. Sanberg</name>
</author>
<author>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
</author>
<author>
<name sortKey="Snow, Barry" sort="Snow, Barry" uniqKey="Snow B" first="Barry" last="Snow">Barry Snow</name>
</author>
<author>
<name sortKey="Warren Olanow, C" sort="Warren Olanow, C" uniqKey="Warren Olanow C" first="C." last="Warren Olanow">C. Warren Olanow</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4FFEC84A3634AFB88899927AE47466D6E748793D</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130303</idno>
<idno type="url">https://api.istex.fr/document/4FFEC84A3634AFB88899927AE47466D6E748793D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000027</idno>
<idno type="wicri:Area/Istex/Curation">000027</idno>
<idno type="wicri:Area/Istex/Checkpoint">003739</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kordower J:fetal:nigral:grafts</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9613726</idno>
<idno type="wicri:Area/PubMed/Corpus">004435</idno>
<idno type="wicri:Area/PubMed/Curation">004435</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004435</idno>
<idno type="wicri:Area/Ncbi/Merge">004F48</idno>
<idno type="wicri:Area/Ncbi/Curation">004F48</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004F48</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kordower J:fetal:nigral:grafts</idno>
<idno type="wicri:Area/Main/Merge">007F16</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:98-0262010</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003041</idno>
<idno type="wicri:Area/PascalFrancis/Curation">003783</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">003016</idno>
<idno type="wicri:doubleKey">0885-3185:1998:Kordower J:fetal:nigral:grafts</idno>
<idno type="wicri:Area/Main/Merge">008140</idno>
<idno type="wicri:Area/Main/Curation">005004</idno>
<idno type="wicri:Area/Main/Exploration">005004</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease</title>
<author>
<name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Research Center for Brain Repair and Department of Neurological Sciences, Rush Presbyterian Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Freeman, Thomas B" sort="Freeman, Thomas B" uniqKey="Freeman T" first="Thomas B." last="Freeman">Thomas B. Freeman</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Division of Neurosurgery, University of South Florida at Tampa</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Chen, Er Un" sort="Chen, Er Un" uniqKey="Chen E" first="Er-Yun" last="Chen">Er-Yun Chen</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Research Center for Brain Repair and Department of Neurological Sciences, Rush Presbyterian Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mufson, Elliott J" sort="Mufson, Elliott J" uniqKey="Mufson E" first="Elliott J." last="Mufson">Elliott J. Mufson</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Research Center for Brain Repair and Department of Neurological Sciences, Rush Presbyterian Medical Center, Chicago</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Sanberg, Paul R" sort="Sanberg, Paul R" uniqKey="Sanberg P" first="Paul R." last="Sanberg">Paul R. Sanberg</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Division of Neurosurgery, University of South Florida at Tampa</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>University of South Florida at Tampa</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Snow, Barry" sort="Snow, Barry" uniqKey="Snow B" first="Barry" last="Snow">Barry Snow</name>
<affiliation>
<wicri:noCountry code="subField">British Columbia</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Warren Olanow, C" sort="Warren Olanow, C" uniqKey="Warren Olanow C" first="C." last="Warren Olanow">C. Warren Olanow</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mt. Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-05">1998-05</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="383">383</biblScope>
<biblScope unit="page" to="393">393</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4FFEC84A3634AFB88899927AE47466D6E748793D</idno>
<idno type="DOI">10.1002/mds.870130303</idno>
<idno type="ArticleID">MDS870130303</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Autopsy</term>
<term>Brain Tissue Transplantation (pathology)</term>
<term>Brain Tissue Transplantation (physiology)</term>
<term>Case study</term>
<term>Corpus Striatum (pathology)</term>
<term>Corpus Striatum (physiopathology)</term>
<term>Corpus striatum</term>
<term>Exploration</term>
<term>Female</term>
<term>Fetal Tissue Transplantation (pathology)</term>
<term>Fetal Tissue Transplantation (physiology)</term>
<term>Fetus</term>
<term>Follow-Up Studies</term>
<term>Gestational Age</term>
<term>Graft</term>
<term>Human</term>
<term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Immunoenzyme Techniques</term>
<term>Immunohistochemistry</term>
<term>Middle Aged</term>
<term>Nerve Regeneration (physiology)</term>
<term>Neurologic Examination</term>
<term>Neuron</term>
<term>Nigral</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (surgery)</term>
<term>Parkinson disease</term>
<term>Putamen (pathology)</term>
<term>Putamen (physiopathology)</term>
<term>Substantia Nigra (embryology)</term>
<term>Substantia Nigra (transplantation)</term>
<term>Tissue Survival (physiology)</term>
<term>Tomography, Emission-Computed</term>
<term>Transplant</term>
<term>Tyrosine 3-Monooxygenase (physiology)</term>
<term>Tyrosine hydroxylase innervation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Tyrosine 3-Monooxygenase</term>
</keywords>
<keywords scheme="MESH" qualifier="embryology" xml:lang="en">
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain Tissue Transplantation</term>
<term>Corpus Striatum</term>
<term>Fetal Tissue Transplantation</term>
<term>Parkinson Disease</term>
<term>Putamen</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Brain Tissue Transplantation</term>
<term>Fetal Tissue Transplantation</term>
<term>Nerve Regeneration</term>
<term>Tissue Survival</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Corpus Striatum</term>
<term>Parkinson Disease</term>
<term>Putamen</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="transplantation" xml:lang="en">
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Gestational Age</term>
<term>Humans</term>
<term>Image Processing, Computer-Assisted</term>
<term>Immunoenzyme Techniques</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Tomography, Emission-Computed</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Autopsie</term>
<term>Corps strié</term>
<term>Etude cas</term>
<term>Exploration</term>
<term>Femelle</term>
<term>Foetus</term>
<term>Greffe</term>
<term>Homme</term>
<term>Immunohistochimie</term>
<term>Neurone</term>
<term>Parkinson maladie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We have previously demonstrated that fetal nigral grafts can survive, reinnervate the striatum, and mediate clinically relevant recovery in a patient with Parkinson's disease (PD).1 Most previous autopsy cases have failed to identify meaningful numbers of viable grafted cells suggesting that differences in critical transplant variables determine graft viability. 2–4 The present study evaluated the structural and functional correlates of fetal nigral transplantation in a second PD patient who received fetal nigral grafts according to our previously published transplant protocol. 5 A 61‐year‐old woman with severe PD received bilateral fetal nigral grafts to the post commissural putamen from seven donor fetuses (four right side and three left side) aged 6.5‐9 weeks postconception. This patient died 19 months after surgery from a cause unrelated to the transplant surgery. Her postoperative clinical course was characterized by improved motor and activities of daily living scores during “off time,” reduced “off time,” and increased “on” time without dyskinesia. Positron emission tomography (PET) scans revealed a bilateral and progressive increase in fluorodopa (FD) uptake within the grafted putamen. Postmortem examination of the right hemisphere revealed large ovalshaped grafts containing more than 138,000 tyrosinehydroxylase‐immunoreactive (TH‐ir) neurons. Grafted cells formed a seamless border with the host and provided dense TH‐ir innervation to 78% of the host postcommissural putamen. Graft‐mediated sprouting of host fibers was not observed. These data provide essential confirmation that, under appropriate transplant conditions, grafted nigral neurons can survive, reinnervate the host striatum, and provide clinical benefit to PD patients. These findings also support the concept that improved motor function and striatal FD uptake on PET after nigral grafting in PD are the result of the viability of grafted neurons and graft‐derived reinnervation of the host striatum.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Floride</li>
<li>Illinois</li>
<li>État de New York</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Snow, Barry" sort="Snow, Barry" uniqKey="Snow B" first="Barry" last="Snow">Barry Snow</name>
</noCountry>
<country name="États-Unis">
<region name="Illinois">
<name sortKey="Kordower, Jeffrey H" sort="Kordower, Jeffrey H" uniqKey="Kordower J" first="Jeffrey H." last="Kordower">Jeffrey H. Kordower</name>
</region>
<name sortKey="Chen, Er Un" sort="Chen, Er Un" uniqKey="Chen E" first="Er-Yun" last="Chen">Er-Yun Chen</name>
<name sortKey="Freeman, Thomas B" sort="Freeman, Thomas B" uniqKey="Freeman T" first="Thomas B." last="Freeman">Thomas B. Freeman</name>
<name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name>
<name sortKey="Mufson, Elliott J" sort="Mufson, Elliott J" uniqKey="Mufson E" first="Elliott J." last="Mufson">Elliott J. Mufson</name>
<name sortKey="Sanberg, Paul R" sort="Sanberg, Paul R" uniqKey="Sanberg P" first="Paul R." last="Sanberg">Paul R. Sanberg</name>
<name sortKey="Warren Olanow, C" sort="Warren Olanow, C" uniqKey="Warren Olanow C" first="C." last="Warren Olanow">C. Warren Olanow</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005004 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005004 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:4FFEC84A3634AFB88899927AE47466D6E748793D
   |texte=   Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024